Option Care Health Announces Financial Results for The Second Quarter Ended June 30, 2024 BANNOCKBURN, Ill., July 31, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Results and Highlights Net revenue of $1,227.2 million, up 14.8% compared to $1,069.1 million in the second quarter of 2023Gross profit of $249.4 million, or 20.3% of ne...
Option Care Health to Announce Second Quarter 2024 Financial Results and Host Conference Call BANNOCKBURN, Ill., July 08, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2024 on Wednesday, July 31, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details ...
Option Care Health to Participate in Upcoming Investor Conferences BANNOCKBURN, Ill., May 16, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: The William Blair 44th Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 4, 2024, including a presentation at 12:00pm CT.The Jefferies Global Healthcare Conference, being held in New York, on Wednesday, June 5, 2024, including a...
Option Care Health to Participate in the BofA Securities Health Care Conference BANNOCKBURN, Ill., April 29, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the BofA Securities Health Care Conference, being held in Las Vegas, on Tuesday, May 14, 2024, including a fireside chat presentation at 2:20pm PT. The webcast will be available online at . About Option Care Health Option Care Health is the nation’s largest independent provider...
Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2024 BANNOCKBURN, Ill., April 23, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results and Highlights Net revenue of $1,146.1 million, up 12.8% compared to $1,015.8 million in the first quarter of 2023Gross profit of $238.5 million, or 20.8% of net rev...
Option Care Health to Announce First Quarter 2024 Financial Results and Host Conference Call BANNOCKBURN, Ill., April 04, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its first quarter ended March 31, 2024 on Tuesday, April 23, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details P...
Option Care Health Reports Financial Results for Fourth Quarter and Full Year 2023 BANNOCKBURN, Ill., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022Gross profit of $247.1 million, or 22.0% of revenue,...
Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the s...
Option Care Health Selects Palantir’s Artificial Intelligence Platform for Enterprise-Wide Digital Transformation DENVER and BANNOCKBURN, Ill., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Palantir Technologies Inc. (NYSE: PLTR), a leading provider of AI systems, and Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, today announced a multi-year commercial partnership for Palantir’s software to be leveraged across the company to help improve patient outcomes and increase efficiency. Option...
Option Care Health to Participate in the J.P. Morgan Healthcare Conference BANNOCKBURN, Ill., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco, on Tuesday, January 9, 2024, including a presentation at 3:00pm PT. The webcast and related presentation materials will be available online at . About Option Care Health Option Care Health is the nation’s...
Option Care Health Announces Increased Share Repurchase Authorization BANNOCKBURN, Ill., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that it anticipates completing the remaining $75 million of repurchases in the fourth quarter under the original authorization. In addition, the Company’s Board of Directors approved an increase to its share repurchase program authorization from $250 million to $500 million. The program...
Option Care Health To Participate In Upcoming Investor Conferences BANNOCKBURN, Ill., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference, being held in London, on Tuesday, November 14, 2023, including a fireside chat at 10:30am GMT/5:30am ET.Bank of America Leveraged Finance Conference, being held in Boca Raton, FL, on Tuesday, November 28, 2023...
Option Care Health Announces Financial Results for the Third Quarter Ended September 30, 2023 BANNOCKBURN, Ill., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the third quarter ended September 30, 2023. Third Quarter 2023 Financial Results and Highlights Net revenue of $1,093.0 million, up 7.1% compared to $1,020.9 million in the third quarter of 2022Gross profit of $254.3 million, or 23.3% of n...
Option Care Health to Announce Third Quarter 2023 Financial Results and Host Conference Call BANNOCKBURN, Ill., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its third quarter ended September 30, 2023 on Wednesday, October 25, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call De...
Option Care Health to Participate in Upcoming Investor Conference BANNOCKBURN, Ill., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the Morgan Stanley 21st Annual Global Healthcare Conference, being held in New York, on Tuesday, September 12, 2023, including a fireside chat at 2:55pm ET. About Option Care Health Option Care Health is the nation’s largest independent provider of home and alternate site infusion service...
Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2023 BANNOCKBURN, Ill., July 27, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Financial Results and Highlights Net revenue of $1,069.1 million, up 9.0% compared to $980.8 million in the second quarter of 2022Gross profit of $250.8 million, or 23.5% of net reven...
Option Care Health to Announce Second Quarter 2023 Financial Results and Host Conference Call BANNOCKBURN, Ill., July 06, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release results for its second quarter ended June 30, 2023 on Thursday, July 27, 2023 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day. Conference Call Details P...
Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™ Company to Deliver to Patients FDA-Approved Topical Treatment for Dystrophic Epidermolysis Bullosa (DEB) Announces Collaboration with Amedisys to Administer Treatment in the Home BANNOCKBURN, Ill., May 23, 2023 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) today announced that it was selected by Krystal Biotech, Inc. (“Krystal Biotech”) (Nasdaq: KRYS) as part of a limited distribution specialty pharmacy network for VYJUVEK™. VYJUV...
Option Care Health to Participate in Upcoming Investor Conferences BANNOCKBURN, Ill., May 18, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will participate in the following upcoming investor conferences: William Blair’s 43rd Annual Growth Stock Conference, being held in Chicago, on Tuesday, June 6, 2023, including a fireside chat at 11:30am CT.The Jefferies Healthcare Conference, being held in New York City, on Wednesday, June 7, 2023, including a ...
Option Care Health to Present at the BofA Securities Health Care Conference BANNOCKBURN, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent national provider of home and alternate site infusion services, will present at the BofA Securities Health Care Conference on Tuesday, May 9, 2023 in Las Vegas. John Rademacher, Chief Executive Officer, and Mike Shapiro, Chief Financial Officer, are scheduled to present at 11:20am PT. Webcast links and related presentation materials will be available online at . Abou...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.